GABA (ácido gamma aminobutírico)

Condiciones de salud que GABA (ácido gamma aminobutírico) puede ayudar a apoyar.

• InflamaciónCientífico

  GABA is the primary inhibitory neurotransmitter in the CNS, with a well-established role in alcohol dependence and addiction. Alcohol acts at GABA-A receptors, and GABA system dysregulation underpins withdrawal craving and anxiety. GABA-modulating agents are core pharmacotherapy for alcohol withdrawal; supplemental GABA is used in integrative addiction protocols to reduce withdrawal anxiety and craving.

• Acidez EstomacalCientífico

  GABA is the primary inhibitory neurotransmitter in the brain, and supplemental GABA has been studied in clinical trials for anxiety and stress reduction. Several small RCTs and a systematic review report anxiolytic effects, particularly at doses of 100–300 mg. Oral GABA bioavailability and CNS penetrance remain areas of ongoing research.

• Envejecimiento (prevención)Científico

  GABA is the brain's primary inhibitory neurotransmitter, and dysregulation of GABAergic signaling is implicated in anxiety, hyperarousal, and stress-related brain fog. Supplemental GABA has been studied for reducing stress-induced cognitive impairment. Some RCTs show GABA supplementation (100–200 mg) reduces stress and anxiety parameters that contribute to mental fog, and promotes relaxed alertness via alpha brain wave enhancement.

• Alergias (respiratorias)Científico

  GABA is the primary inhibitory neurotransmitter, and its signaling is consistently dysregulated in burnout, manifesting as anxiety, hypervigilance, and sleep disruption. Supplemental GABA has been studied in RCTs for stress and anxiety reduction. A Japanese RCT found that GABA supplementation significantly reduced psychological stress and fatigue after a stressful task vs. placebo.

• AmenorreaCientífico

  GABA is the primary inhibitory neurotransmitter in the CNS, reducing neuronal excitability to produce calming effects. A 2020 PRISMA systematic review (Frontiers in Neuroscience) found prolonged oral use improved sleep disturbance and calmness subscores in some RCTs. Blood-brain barrier penetration limitations exist, but gut-brain axis pathways may partly explain calming outcomes. Studied doses range from 100–300 mg/day.

• Apetito (deficiente)Científico

  GABA is the primary inhibitory neurotransmitter and plays a central mechanistic role in sleep-wake cycle regulation. GABAergic neurons in the ventrolateral preoptic area drive sleep onset by inhibiting wake-promoting systems. A 2019 PMC study found GABA combined with L-theanine decreased sleep latency by 41.6% and improved NREM sleep architecture.

• Trastorno por Déficit de AtenciónCientífico

  GABA deficiency is consistently found in patients with depression, evidenced by reduced occipital and prefrontal cortex GABA levels on MRS neuroimaging. Multiple antidepressants increase GABAergic neurotransmission as part of their mechanism. Oral GABA supplementation has shown modest anxiolytic and mood-supporting effects in limited clinical studies.

• Control de Natalidad (contrarrestando los efectos secundarios)Científico

  GABA is the principal inhibitory neurotransmitter regulating emotional reactivity, fear, and stress responses. Oral GABA supplementation in small RCTs has demonstrated reductions in psychological and physiological stress markers, alpha wave induction, and stress-induced fatigue reduction. Evidence supports a functional role via gut-brain or enteric GABAergic pathways.

• Sangre en la OrinaCientífico

  GABA is the primary inhibitory neurotransmitter associated with reducing anxiety and mental stress, which can indirectly support focus and concentration. Japanese clinical studies with food-derived GABA report improvements in task-focused concentration and reduced mental fatigue. Mechanistic questions about oral GABA's ability to cross the blood-brain barrier remain, with peripheral or enteric routes proposed.

• ForúnculosCientífico

  Multiple clinical trials have demonstrated that oral GABA supplementation (3 g) significantly elevates resting and post-exercise GH concentrations. A randomized double-blind crossover study (Powers et al., 2008, PMID 18091016) in 11 resistance-trained men found significant increases in immunoreactive and immunofunctional GH at rest and augmented exercise-induced GH. A 12-week RCT (Sakashita et al., JOCMR, 2019) showed elevated resting plasma GH at 4 and 8 weeks and greater fat-free mass gains with GABA plus whey vs. whey alone.

• Senos (aumentar tamaño)Científico

  GABA is the brain's primary inhibitory neurotransmitter and is also synthesized in significant amounts by gut bacteria (notably Lactobacillus and Bifidobacterium species). Gut-derived GABA can signal to the brain via the enteric nervous system and vagal pathways, making it a direct molecular mediator of the gut-brain axis. Research links gut GABA production to anxiety, depression, and stress regulation.

• Debilidad CapilarCientífico

  GABA is the principal inhibitory neurotransmitter and is directly implicated in sleep regulation. Oral GABA supplementation has been studied in randomized controlled trials for insomnia, showing reductions in sleep latency and improvements in subjective sleep quality. Its GABAergic mechanism is well-established.

• Enfermedad CelíacaCientífico

  GABA is the primary inhibitory neurotransmitter of the CNS and plays a critical role in neural signal regulation, reducing cognitive noise and enabling focused attention. Oral GABA supplementation has been shown in RCTs to improve relaxed alertness, reduce cognitive fatigue, and enhance performance under stress. Its role in learning consolidation during sleep is also well established.

• Colesterol (bajo)Científico

  Supplemental GABA influences brain function through gut-brain axis signaling. Clinical studies using PharmaGABA (natural-source GABA) show improvements in alpha brain wave activity, focused alertness, and reduction of anxiety-induced mental fog.

• Resfriados (con fiebre)Científico

  GABA is the principal inhibitory neurotransmitter in the central nervous system, present in approximately 25–50% of CNS neurons. It plays a major role in spinal motor networks, seizure suppression, and modulation of neuronal excitability. Oral GABA supplement research is ongoing regarding blood-brain barrier penetration.

• ColitisCientífico

  GABA is the brain's primary inhibitory neurotransmitter; its deficiency is associated with depression, anxiety, and epilepsy. Major depressive disorder coincides with diminished brain GABA levels. Oral GABA supplementation may act via the enteric nervous system and gut-brain axis, with emerging evidence supporting peripheral and potentially central effects.

• ConfusiónCientífico

  GABA is the primary inhibitory neurotransmitter in the CNS and is directly implicated in the neurobiology of anxiety and panic disorders. Oral GABA supplementation (100 mg) has been shown in human studies to increase alpha brain waves and decrease beta brain waves associated with stress and anxiety. A 2025 mouse RCT published in npj Science of Food demonstrated that oral GABA significantly alleviated anxiety-like behaviors by modulating neuroinflammatory and complement pathways.

• Congestión (bronquial)Científico

  GABA is the primary inhibitory neurotransmitter, with declining availability during perimenopause contributing to anxiety, insomnia, and mood instability. Revolution Health's evidence-based perimenopause guidance lists GABA supplements for mood stabilization. Progesterone's metabolite allopregnanolone is a potent GABA-A modulator, and its decline during perimenopause directly impairs GABAergic signaling.

• Dolor de cabeza (sinusal)Científico

  GABAergic dysfunction is mechanistically implicated in RLS, and GABA is listed among supplements promoted for RLS by ConsumerLab. Pharmaceutical GABA analogs (gabapentin, pregabalin) are FDA-approved for RLS, providing strong indirect evidence that GABAergic supplementation is mechanistically relevant.

• Calambres (menstruales)Científico

  Oral GABA has been shown in a randomized, double-blind trial to improve sleep parameters including nighttime awakenings and overall sleep quality in insomnia patients. GABA increases alpha-wave brain activity (relaxation) and reduces beta-wave activity (arousal), supporting sleep maintenance. It is the principal inhibitory neurotransmitter and a mechanistic backbone for sleep continuity regulation.

• Calambres y EspasmosCientífico

  GABA is the primary inhibitory neurotransmitter of the CNS and a central target for virtually all pharmacological hypnotic drugs. Exogenous GABA supplementation and GABA combined with L-theanine have been shown in controlled studies to decrease sleep latency and improve NREM sleep in animal and human research.

• Enfermedad de CrohnCientífico

  GABA is the principal inhibitory neurotransmitter in the CNS and plays a central role in sleep regulation by suppressing wake-promoting systems. Oral GABA has been explored as a sleep supplement, with some evidence suggesting it can reduce sleep latency and improve NREM sleep, particularly in combination with L-theanine. A 2024 double-blind RCT combining GABA with Poria cocos and Ziziphus spinosa significantly improved PSQI scores. Evidence for oral GABA alone remains limited due to uncertain CNS bioavailability.

• Fibrosis QuísticaCientífico

  The primary inhibitory neurotransmitter of the central nervous system, with a known role in stress regulation. Small clinical studies and emerging evidence via the gut-brain axis suggest oral GABA supplementation reduces stress and promotes relaxation. Widely consumed in Japan and East Asia for stress management.

Sistemas corporales que GABA (ácido gamma aminobutírico) puede ayudar a apoyar.

• No hay sistemas corporales disponibles.